Cargando…

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.

Detalles Bibliográficos
Autores principales: Outterson, Kevin, Gopinathan, Unni, Clift, Charles, So, Anthony D., Morel, Chantal M., Røttingen, John-Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907461/
https://www.ncbi.nlm.nih.gov/pubmed/27299990
http://dx.doi.org/10.1371/journal.pmed.1002043
_version_ 1782437544303001600
author Outterson, Kevin
Gopinathan, Unni
Clift, Charles
So, Anthony D.
Morel, Chantal M.
Røttingen, John-Arne
author_facet Outterson, Kevin
Gopinathan, Unni
Clift, Charles
So, Anthony D.
Morel, Chantal M.
Røttingen, John-Arne
author_sort Outterson, Kevin
collection PubMed
description Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.
format Online
Article
Text
id pubmed-4907461
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49074612016-07-18 Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality Outterson, Kevin Gopinathan, Unni Clift, Charles So, Anthony D. Morel, Chantal M. Røttingen, John-Arne PLoS Med Essay Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics. Public Library of Science 2016-06-14 /pmc/articles/PMC4907461/ /pubmed/27299990 http://dx.doi.org/10.1371/journal.pmed.1002043 Text en © 2016 Outterson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Essay
Outterson, Kevin
Gopinathan, Unni
Clift, Charles
So, Anthony D.
Morel, Chantal M.
Røttingen, John-Arne
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title_full Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title_fullStr Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title_full_unstemmed Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title_short Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality
title_sort delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality
topic Essay
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907461/
https://www.ncbi.nlm.nih.gov/pubmed/27299990
http://dx.doi.org/10.1371/journal.pmed.1002043
work_keys_str_mv AT outtersonkevin delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality
AT gopinathanunni delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality
AT cliftcharles delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality
AT soanthonyd delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality
AT morelchantalm delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality
AT røttingenjohnarne delinkinginvestmentinantibioticresearchanddevelopmentfromsalesrevenuesthechallengesoftransformingapromisingideaintoreality